Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript October 30, 2024
Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.41, expectations were $0.28.
Operator: Good day and thank you for standing by. Welcome to the Corcept Therapeutics Conference Call. At this time, all participants are in listen-only mode. After speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that...
